Drug class
Murine monoclonal anti-NCA-95 antibody; diagnostic radiopharmaceutical precursor (99mTc-labelled kit)
Mechanism of action
Binds the NCA-95 antigen on granulocytes. Following radiolabelling with technetium-99m, the antibody carries radioactivity to granulocyte-rich sites of infection or inflammation, allowing scintigraphic localisation.
General use cases
- Diagnostic scintigraphic imaging, alongside other appropriate imaging modalities, to locate peripheral bone infection/inflammation in adults with suspected osteomyelitis; not for diagnosing diabetic-foot infection
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
